In its response to the statement of objections, Aventis argues that only RPB should be held responsible for the infringement. The only argument in support of this claim is the statement cited in recital 209(142). Aventis does not attempt to explain the circumstances under which [Aventis employee 3] wrote the note of 6 November 1991, nor does it address the influence of Aventis Pharma on decision making in Rhône-Poulenc Biochimie.
Recital 213, Decision_act (EU) 2004/104
In forcesince 27 Nov 2002